Arkolith/Insider Trading/KIN/Form 4

Chin Richard

Chief Executive Officer, DirectorKindred Biosciences, Inc. (KIN) · full profile →Form 4 · filed Jul 7, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$367K
Net Open-Market Flow
-$367K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2021Sell(S)40K$9.18$367K1.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001250853-21-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML